Regenerative Medicine Market, By Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, and Gene Therapy), By Product Type (Cell-Based Products (Allogeneic Products and Autologous Products) and Acellular Products), By Application (Orthopedic & Musculoskeletal Disorders, Dermatology, Cardiology, Dermatology, Diabetes, Central Nervous System Disorders, and Others), and By Region - Trends, Analysis and Forecast till 2030

Report Code: PMI380220 | Publish Date: August 2023 | No. of Pages: 165

Global Regenerative Medicines Market By Overview

Regenerative Medicine Market accounted for USD 7.5 billion in 2020 and is estimated to be US$ 31.44 billion by 2030 and is anticipated to register a CAGR of 15.4%.

Regenerative medicines are used to heal, replace, and regenerate tissues and organs affected by the disease, injury, or natural ageing process. Regenerative medicine is the process where the body uses its systems, sometimes with the help of foreign biological material to repairs or replace tissue or organ function. It has the potential to solve the current problem of organ shortage accessible through donation, as there exists a huge patient pool who are still waiting for organ donation. Regenerative medicine makes use of stem cells and is established in a laboratory which is then safely implanted into the body when the body cannot heal itself. Moreover, it enhances the quality of life of an individual.

Regenerative Medicine Market

Global Regenerative Medicines Market By Drivers & Restraints

Rising number of collaborations

The rising number of collaborations by key market players with government funding and research institutes is projected to drive the growth of the global regenerative medicines market over the forecast period. According to data published by Alliance for Regenerative Medicine (ARM), the global financing in 2016 for the regenerative medicine was estimated at US$ 5.22 billion. Out of this, US$ 2.97 billion was for cell therapy segment.

Increasing awareness about benefits of stem cell therapies

Also, increasing awareness about the benefits of stem cell therapies is anticipated to boost the growth of the target market over the forecast period. Moreover, the growing number of cases for genetic and chronic diseases and regenerative medicine providing an alternative solution for convention methods is propelling the growth of the target market. However, stringent government regulation and high investment required for developing the medicine are major factors hampering the growth of the global regenerative medicines market. Nevertheless, the developing nations are focused on technological advancements which in turn creates lucrative growth opportunities for the target market.

Global Regenerative Medicines Market By Segmentations & Regional Insights

Regenerative medicines market is segmented based on therapy, product type, application, and region.

Based on therapy, the global regenerative medicines market is segmented into cell therapy, tissue engineering, immunotherapy, and gene therapy. The cell therapy segment is dominating the target market and is expected to maintain its dominance over the forecast period. This is attributed due to its efficiency to restore the lost function of tissues and organs. Based on product type, the target market is segmented into cell-based products and acellular products. The cell-based products are further bifurcated into allogeneic products and autologous products.

Regional Insights:

For detailed understanding of market dynamics, based on the region the global regenerative medicines market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America dominates the global regenerative medicine market in terms of revenue contribution as related to that of markets in other regions. This is attributed to the increasing government funds for the development of regenerative medicines and the presence of dominant players in the market in this region. Europe estimates for second-highest revenue share contribution to the global regenerative medicine, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is anticipated to witness comparatively faster growth in terms of revenue over the forecast period due to the growing prevalence of chronic diseases. Besides, the global market players are spending in developing economies such as India and China.

Regenerative Medicine Market Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Therapy- Cell Therapy, Tissue Engineering, Immunotherapy, And Gene Therapy

By Product Type- cell-based products and acellular products

By Application- Orthopedic & Musculoskeletal Disorders, Dermatology, Cardiology, Dermatology, Diabetes, Central Nervous System Disorders, and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Regenerative Medicines Market, By Therapy:

  • Cell Therapy
  • Tissue Engineering
  • Immunotherapy
  • Gene Therapy

Regenerative Medicines Market, By Product Type:

  • Cell-Based Products
    • Allogeneic Products
    • Autologous Products
  • Acellular Products

Regenerative Medicines Market, By Application:

  • Orthopedic & Musculoskeletal Disorders
  • Dermatology
  • Cardiology
  • Dermatology
  • Diabetes
  • Central Nervous System Disorders
  • Others

Regenerative Medicines Market, By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa

Global Regenerative Medicines Market By Competitive Landscape & Key Players

The key players operating the regenerative medicines market involves Organogenesis, Inc., Osiris Therapeutics, Inc., Pfizer Inc., Novartis AG, Vericel Corporation, NuVasive, Inc., Cook Biotech, Inc., GlaxoSmithKline plc., Boehringer Ingelheim GmbH, and Amgen, Inc. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market.

Regenerative Medicine Market Players

Global Regenerative Medicines Market By Recent News

  • In March 2024, New technique for Parkinson's stem cell brain repair brings promise for patients. Neuroscientists at the University of Galway have made an exciting discovery that could revolutionize stem cell-based brain repair therapy for Parkinson's disease.
  • In January 2024, Osteoporosis treatment; Unlocking hope for patients with regenerative medicine. Osteoporosis threatens millions due to the unseen epidemic but with rise of regenerative therapies, there's hope.
  • In January 2024, WFIRM took $40M regenerative medicine initiative for the wounded and beyond. The Wake Forest Institute for Regenerative Medicine, part of Wake Forest University School of Medicine, has been awarded a $40 million, five-year project by the Defence Health Agency to lead the Armed Forces Institute of Regenerative Medicine Consortium.

Global Regenerative Medicines Market By Company Profile

  • Organogenesis, Inc.
    • Company Overview
    • Therapy Portfolio
    • Key Highlights
    • Financial Performance
  • Osiris Therapeutics, Inc.
  • Pfizer, Inc.
  • Novartis AG
  • Vericel Corporation
  • NuVasive, Inc.
  • Cook Biotech, Inc.
  • GlaxoSmithKline plc.
  • Boehringer Ingelheim GmbH
  • Amgen, Inc.

FAQs

The global regenerative medicines market is segmented based on therapy, product type, application, and region.

The rising number of collaborations by key market players with government funding and research institutes is projected to drive the growth of the global regenerative medicines market over the forecast period.

North America dominates the global regenerative medicine market in terms of revenue contribution as related to that of markets in other regions. This is attributed to the increasing government funds for the development of regenerative medicines and the presence of dominant players in the market in this region.

The key players operating the global regenerative medicines market involves Organogenesis, Inc., Osiris Therapeutics, Inc., Pfizer Inc., Novartis AG, Vericel Corporation.